Articles On Hera Med (ASX:HMD)

Title Source Codes Date
HeraMED (ASX:HMD) raises $2.39m via convertible note placement

Medical tech company HeraMED (HMD) raises roughly $2.39 million through a convertible note placement The placement was strongly supported by institutional and sophisticated investors The proceeds will fast-track the commercial roll out of...

themarketherald.com.au HMD 1 day ago
ASX Health Stocks: Proteomics jumps 13pc on diabetes test

It’s been a busy morning for the ASX Healthcare sector, with plenty of positive announcements for investors to digest. But the Health Index (XHJ) is trading down by 0.5% at the time of writing, compared to the broader index which is trading...

Stockhead HMD 1 day ago
Closing Bell: ASX enters the weekend with second straight day of gains

It’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher than yesterday, closing at 7,362 which marked a 3 week high but is still 3.5% above the all time high reached in mid-August. Travel stocks gai...

Stockhead HMD 4 days ago
Closing Bell: Gold spikes and tech stocks catch a bid in bullish session

Local stocks posted a strong session on Thursday, as the ASX 200 climbed by around 1% while the microcap Emerging Markets index jumped again (+1.9%). Asian markets were buoyant more broadly, following a steady session on Wall Street overnig...

Stockhead HMD 5 days ago
HeraMED (ASX:HMD) halts trade, eyes capital raise

Pregnancy technology company HeraMED (HMD) enters a trading halt while it considers, plans and executes a capital raising The company will remain in the halt until October 18 or when an announcement is made released, whichever occurs firs...

themarketherald.com.au HMD 5 days ago
“Your Stock Request” – 16 September 2021

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fairmont Equities HMD 1 month ago
From Mesoblast to Metcash: Ten ASX stocks that made a splash today

Highlights Biotechnology firm Mesoblast extended its loss on disappointing earnings and dropped 5%. Graphite producer Volt Resources dropped despite successfully raising capital via share placement. Medical data and technology firm He...

Kalkine Media HMD 1 month ago
ASX slips 1% amid broad-based sell-off; Q2 GDP beats estimates

Highlights The ASX 200 declined as much as 1% by lunchtime as investors awaited June quarter GDP figures. Australia’s Q2 GDP rose 0.7% in the June quarter. Barring energy, all indices were trading in the red, while healthcare declined...

Kalkine Media HMD 1 month ago
Hidden Gems Webinar Recap – EXL, WOA, OSX & HMD

ShareCafeHidden Gems Webinar Recap – EXL, WOA, OSX & HMD Catch up on the full webinar with presentations from  Elixinol Wellness (ASX: EXL), Wide Open Agriculture (ASX: WOA), Osteopore (ASX: OSX)  & HeraMED (ASX: HMD). Hidden Gems...

ShareCafe HMD 3 months ago
“Your Stock Request” – 27 May 2021

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fairmont Equities HMD 4 months ago
Three ASX healthcare shares on the rise today – AHI, PCK, 4DX

Summary Advanced Human Imaging has entered into a binding agreement with Jana Care to bring affordable digitally connected care to everyone. PainChek Infant has obtained the necessary regulatory approvals in multiple International mark...

Kalkine Media HMD 4 months ago
HeraMED (ASX:HMD) share price tanks despite US healthcare deal

The HeraMED Ltd (ASX: HMD) share price tanked today, closing 9% lower at 15 cents apiece. This came despite the company signed a pilot deal with Obstetrix Medical, one of the USA’s largest women’s and children’s healthcare providers. HeraM...

Motley Fool HMD 5 months ago
Last Orders: ASX retreats following the budget; over fears of AAA credit rating loss & early rate hikes

While there appeared to be several winners out of Budget 2021, few of them were on the ASX. The ASX 200 fell for the second day in a row losing 0.73 per cent to close at 7,045 points. Meanwhile the ASX Emerging Companies Index fell 0.51 per...

Stockhead HMD 5 months ago
Last Orders: ASX retreats after yesterday’s record high

After closing at a record high yesterday the ASX retreated by nearly 1 per cent today. The ASX 200 lost 1.06 per cent to close at 7,097 points. The ASX Emerging Companies Index fared worse closing 2.3 per cent in the red – at 2,060 points....

Stockhead HMD 5 months ago
April Winners Column: Resources re-takes the mantle, led by one stock that gained nearly 500pc

Google April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. Just another month in the pandemic, right? Well, yes and no. On one hand the vaccine race continues across the world – far slower than we’d l...

Stockhead HMD 5 months ago
Telemedicine witnesses a boom amid COVID-19: A look at 3 ASX stocks  

Summary With the current emergency, it is anticipated that telehealth or telemedicine could be the future of medicine. COVID-19 pandemic resulted in considerable adoption of telehealth solutions, mainly to avoid physical contact. The...

Kalkine Media HMD 5 months ago
HeraMED secures landmark commercial agreement with Joondalup Health Campus

HeraMED has announced a paid pilot with a leading medical provider for 100 expectant mothers. HeraMED’s (ASX:HMD) HeraCARE platform will be rolled out to 100 expectant mothers at WA’s Joondalup Health Campus as part of a landmark paid pilo...

Stockhead HMD 5 months ago
Last Orders: ASX slides again – falls below 7,000 mark

The ASX fell again today, as risk-on sentiment continued to reign supreme in the markets. The ASX 200 fell 0.29 per cent, a smaller drop then yesterday but one that saw it close below 7,000 – at 6,997. Small caps fell by more, with the ASX...

Stockhead HMD 5 months ago
Last Orders: ASX ends 5 day winning streak but still above 7,000

The ASX 200 has finished the day in the red but is still above 7,000 points. The ASX 200 shed 0.68 per cent closing at 7,018 points while the ASX Emerging Companied Index fell 0.33 per cent, closing at 2,101 points. All sectors were in the...

Stockhead HMD 5 months ago
Leading scientific publication backs HeraMED’s foetal heartbeat monitor

The official publication of the American College of Obstetricians and Gynecologists has endorsed the results of a clinical trial into HeraMED’s foetal monitoring device. HeraMED (ASX:HMD) is a step closer to commercialisation following the...

Stockhead HMD 7 months ago
A Glance at the Financial Performance of HeraMED and Adherium

Source:New Africa ,Shutterstock Summary COVID-19 had a significant impact on the HeraMED’s and Adherium’s first half 2021 results. However, the two players made critical developments during the period. HeraMED plans to expand further...

Kalkine Media HMD 7 months ago
5 ASX penny stocks in healthcare space

Summary With COVID-19 giving the opportunity to develop products, enhance services and conduct R&D, healthcare sector will be vigilantly gauged. Early spotting of a winning penny stock can offer considerable rewards to patient and...

Kalkine Media HMD 7 months ago
How did 1H FY21 turn out for Global Health (ASX:GLH)?

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

Kalkine Media HMD 8 months ago
Global Health (ASX: GLH): Lifecard Patient Portal demand magnifies

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

Kalkine Media HMD 10 months ago
Why HeraMed (ASX:HMD) and Dimerix (ASX:DXB) are trending?

Summary HeraMED’s partnership with eCare21 aims to fast-track awareness of HeraCARE and HeraBEAT across the US. Dimerix drug compound DMX-200 is set to be tested for COVID-19-induced ARDS in the global study. Dimerix is confident that...

Kalkine Media HMD 11 months ago
HeraMED teams up with eCare21 to deliver smart solution for in-home maternity care to US patients

Maternity-focused technology start-up HeraMED (ASX: HMD) has signed an agreement with US virtual care provider eCare21 to integrate its smart pregnancy monitoring solutions into eCare21’s software-as-a-service (SaaS) platform. Under the agr...

SmallCaps HMD 1 year ago
New investors back HeraMed’s latest raise to the tune of $2.3m

Special Report: Maternity health digitiser HeraMED has raised serious cash from new and existing sophisticated and institutional investors to speed the rollout of its software platform HeraCARE. HeraMED (ASX:HMD) has raised $2.32m to speed...

Stockhead HMD 1 year ago
HeraMED gets set for Aussie clinical trials with new deal

Special Report: Maternal health tech company HeraMED is preparing for clinical trials in Australia with a new partnership. HeraMED (ASX:HMD) is getting ready to run clinical trials for its maternity care telehealth and remote monitoring so...

Stockhead HMD 1 year ago
HeraMED ramps up Australian strategy with new distribution deal

Special Report: Medical tech company HeraMED has signed an exclusive deal to distribute its foetal heart rate monitors in Australia. HeraMED (ASX:HMD) is accelerating its commercialisation strategy with an exclusive two-year Australian dist...

Stockhead HMD 1 year ago
VidCon Recap: Here are the most important things we learned about the future of telehealth

As we approach the middle of 2020, the investment environment surrounding the fallout from the COVID-19 pandemic remains complex. Along with threats, there will be plenty of opportunities. And it’s against that backdrop that this week marke...

Stockhead HMD 1 year ago
Stockhead VidCon: The Future of TeleHealth

VidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions and presentations on the most interesting and relevant investment sectors from leading analysts, listed small caps and industry participant...

Stockhead HMD 1 year ago
StockDoc Podcast: HeraMED’s telehealth offering for pregnant women is booming under COVID-19

Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast. In this episode the good doctor sits down with Alexander Radke, general manager...

Stockhead HMD 1 year ago
Stock Talk: TeleHealth in a COVID-19 world and beyond

Stock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this first edition, host Dr Nigel Finch examines the coronavirus-induced boom of the telehealth industry. Populatin...

Stockhead HMD 1 year ago
HeraMED in ‘advanced discussions’ for roll-out of telehealth maternity software as COVID-19 rampages

Maternity telehealth company HeraMED (ASX: HMD) revealed this morning in a conference call it was in “advanced discussions” regarding the expedited commercial roll-out of its platform across the US, UK, Australia and Israel. The company’s H...

SmallCaps HMD 1 year ago
HeraMed’s telehealth solutions address self-isolation needs

HeraMED Limited (ASX:HMD), a medical technology company leading the digital transformation of maternity care with its proprietary in-home maternity care platform, advised on Tuesday morning that it had received a significant uplift in inter...

FinFeed HMD 1 year ago
Remote control: 5 medtechs set to benefit from the surge in demand for tele-health solutions

The coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves. But as with any major correction, some industries feel the brunt of the impact while for others, the dramatic shift presents an opportunity....

Stockhead HMD 1 year ago
HeraMED’s hybrid maternity care platform poised for market testing

Special Report: HeraMed’s fast-tracked development process has paid dividends as its flagship product nears pilot testing. Medical technology company HeraMED’s (ASX:HMD) proprietary hybrid maternity care platform, HeraCARE, is now fully fu...

Stockhead HMD 1 year ago
Health: Compumedics wins FDA approval for its brain scanners, leaps 20pc

Another ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its products enter the US market. This morning it was Compumedics (ASX:CMP). Its signature product, the Orion LifeSpan Magnetoencephalography single De...

Stockhead HMD 1 year ago
HeraMED (ASX:HMD) appoints General Manager to support U.S. market entry

HeraMED (HMD) has appointed Alexander Radke as General Manager of its U.S. operations Alexander has previously held senior roles and has vast experience in the U.S. healthcare market He will use his expertise to develop the company’s strat...

themarketherald.com.au HMD 1 year ago
HMD Set to Create One of the World’s Most Advanced AI-Based Pregnancy Monitoring Diagnostic Tools

2020 could be the year HeraMED (ASX:HMD) comes of age and it all has to do with its Artificial Intelligence (AI) platform, a cloud based machine learning software-as-a-service (SaaS) platform, known as OrionAI.

NextTechStock HMD 1 year ago
HeraMED (ASX:HMD) accesses unique pregnancy database to strengthen OrionAI

HeraMED (HMD) has received roughly 90,000 pregnancy monitoring records from the Mayo Clinic via their recent collaboration This is key in progressing the Orion AI platform, a cloud-based platform that analyses pregnancy records and detects...

themarketherald.com.au HMD 1 year ago
Mayo Clinic provides HeraMED with a massive dataset of pregnancy records

Medical technology company, HeraMED Limited (ASX:HMD) has received approximately 90,000 pregnancy records from research and development collaborator the Mayo Clinic, which will be implemented into its OrionAI platform. This provides HeraMED...

FinFeed HMD 1 year ago
Why You Can Expect a Boom in Healthcare Space in 2020: A Glance at 7 Health Care Stocks

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

Kalkine Media HMD 1 year ago
Artificial Intelligence in Healthcare: Harrison.ai and HeraMED Under Discussion

Technology undoubtedly holds a significant importance in each sector of the industry, more so than ever, and certainly health care sector is no different. Use of technologies in the health care sphere has emerged as a boon for doctors, rese...

Kalkine Media HMD 1 year ago
HeraBEAT users could be in line for full refunds on the cost of the product

Medical technology company, HeraMED Limited (ASX:HMD) is pursuing verification around the potential for its HeraBEAT and HeraCARE solutions to be reimbursed under the US reimbursement code system. Should this occur, under new CPT (Current P...

FinFeed HMD 1 year ago
HeraMED CEO David Groberman talks about the company’s progress

The Mayo Clinic has been established for more than 150 years, and employs more than 4500 physicians and scientists along with 54,000 allied health staff across 19 hospitals in five US states. It has been ranked No 1 hospital in the world fo...

FinFeed HMD 1 year ago
Integration of Health Care with Technology, Looking through 2020s

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction of technologies in the health care domain emerged as the biggest blessing not only for pa...

Kalkine Media HMD 1 year ago
HeraMED’s HeraBEAT endorsed by prominent Indian healthcare group

Medical technology group, HeraMED Limited’s (ASX:HMD) distributor based in India has secured a commercial service partnership with Cloudnine Hospital Group to initiate a commercial pilot allowing expecting mothers in the Cloudnine network t...

FinFeed HMD 1 year ago
HeraMed to Spring-Board German Pre Natal Market Entry by Partnering with Telehealth Provider...

HeraMED (ASX:HMD) has signed an agreement with Kinderheldin to add online midwifery service to be offered as HeraBEAT PLUS in Germany.

NextTechStock HMD 1 year ago
HeraMED continues to forge value adding partnerships

The good news keeps flowing for medical technology company, HeraMED Limited (ASX:HMD) with the company announcing today that it has entered into an agreement with leading midwife service provider, Kinderheldin GmbH. This follows news earlie...

FinFeed HMD 1 year ago